A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis

Journal of the American Society of Nephrology

Volumn 10, Issue 6, 1999, Pages 1224-1233

  Witko Sarsat, Veronique ^a   Lesavre, Philippe ^a   Lopez, Sandra ^a   Bessou, Gilles ^a   Hieblot, Corinne ^a   Prum, Bernard ^d   Noël, Laure Hélène ^a   Guillevin, Loïc ^b   Ravaud, Philippe ^c   Sermet Gaudelus, Isabelle ^a   Timsit, José ^a   Grünfeld, Jean Pierre ^a   Halbwachs Mecarelli, Lise ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b AVICENNE HOSPITAL   (France)

^c Hôpital Cochin ^*  (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; MEMBRANE PROTEIN; METHOTREXATE; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; PREDNISONE; PROTEINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CELL SUBPOPULATION; CHILD; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; ENZYME ASSAY; ENZYME ISOLATION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; RISK FACTOR; VASCULITIS;

EID: 0032991087     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v1061224     Document Type: Article

References (27)

1. Van der Woude FJ: Autoantibodies to neutrophils and monocytes: A new tool for diagnosis and a marker of disease activity in Wegener's granulomatosis. Lancet 1: 425-429, 1985
2. Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, Hack CE, van den Ende ME, Kallenberg CG, von dem Borne AE: Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 84: 1577-1587, 1989
3. Ludemann J, Utecht B, Gross WL: Anti-cytoplasmic antibodies in Wegener's granulomatosis are directed against proteinase 3. Adv Exp Med Biol 297: 141-150, 1991
4. Lesavre P: Antineutrophil cytoplasmic autoantibodies antigen specificity. Am J Kidney Dis 18: 159-163, 1991
5. Halbwachs-Mecarelli L, Bessou G, Lesavre P, Lopez S, Witko-Sarsat V: Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett 374: 29-33, 1995
6. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG: Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994
7. Lesavre P, Noël LH, Gayno S, Nusbaum P, Reumaux D, Erlinger S, Grünfeld JP, Halbwachs-Mecarelli L: Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): Specificity and clinical associations. J Autoimmun 6: 185-195, 1993
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324, 1988
9. Dougados M, van der Linden S, Juhlin R: The European Spondylarthropathy Study Group: Preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34: 1218-1227, 1991
10. Stern RC: The diagnosic of cystic fibrosis. N Engl J Med 336: 487-491, 1997
11. Csernok E, Schmitt W, Ernst M, Bainton D, Gross W: Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides. Adv Exp Med Biol 336: 45-50, 1993
12. Sommarin Y, Rasmussen N, Wieslander J: Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies. Exp Nephrol 3: 249-255, 1995
13. Henson PM, Zanolari B, Schwartzman NA, Hong SR: Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B. J Immunol 121: 851-856, 1973
14. Kishimoto TK, Jutila MA, Berg EL, Butcher EC: Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotatic factors. Science 245: 1238-1241, 1989
15. Borregaard N, Kjeldsen L, Sengelov H, Diamond MS, Springer TA, Anderson HC, Kishimoto TK, Bainton DF: Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J Leukocyte Biol 56: 80-87, 1994
16. Dale DC, Fauci AS, Guerry D, Wolf SM: Comparison of agents producing a neutrophilic leukocytosis in man: Hydrocortisone, prednisone, endotoxin, etiocholanolone. J Clin Invest 56: 803-813, 1975
17. Lopez S, Halbwachs-Mecarelli L, Ravaud P, Bessou G, Dougados M, Porteu F: Neutrophil expression of tumour necrosis factor receptors (TNF-R) and of activation markers (CD11b, CD43, CD63) in rheumatoid arthritis. Clin Exp Immunol 101: 25-32, 1995
18. Cantin A: Cystic fibrosis lung inflammation: Early, sustained and severe. Am J Respir Crit Care Med 151: 939-941, 1995
19. Falk R, Terrel R, Charles L, Jennette J: Antineutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce toxic oxygen radicals in vitro. Proc Natl Acad Sci USA 87: 4115-4119, 1990
20. Charles L, Caldar M, Falk R, Terrell R, Jennette J: Antibodies against granule proteins activate neutrophils in vitro. J Leukocyte Biol 50: 539-546, 1992
21. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL: Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95: 244-250, 1994
22. Witko-Sarsat V, Moog-Lutz C, Lopez S, Hieblot C, Cayre Y, Lesavre P, Halbwachs-Mecarelli L: Membrane expression of proteinase 3 is associated with the degranulation of a highly mobilizable compartment of neutrophils distinct from azurophilic granules: Evidence of PR3 in mature neutrophils [Abstract]. Eur J Haematol 60: 335, 1998
23. Bangalore N, Travis J: Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G. Biol Chem Hoppe-Seyler 375: 659-666, 1994
24. Owen CA, Campbell EJ: Neutrophil proteinases and matrix degradation: The cell biology of pericellular proteolysis. Semin Cell Biol 6: 367-376, 1995
25. Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, Hoidal JR: Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase: Structural and functional properties. J Biol Chem 266: 9540-9548, 1991
26. Padrines M, Wolf M, Walz A, Baggiolini M: Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett 352: 231-235, 1994
27. Robache-Gallea S, Morand V, Bruneau JM, Schoot B, Tagat E, Réalo E, Chouaib S, Roman-Roman S: In vitro processing of human tumor necrosis factor-α. J Biol Chem 270: 23688-23692, 1995